Bill > HB0070

This bill requires TennCare health benefit plans, starting July 1, 2025, to provide coverage and reimbursement for biomarker testing for preeclampsia in pregnant women. The bill defines several key terms, including "biomarker" as a measurable characteristic indicating biological processes or responses, and "biomarker test" as an analysis of tissue, blood, or other specimens using FDA-approved methods like genome sequencing or protein expression testing. Under the bill, pregnant women can be screened for preeclampsia using biomarker testing when ordered by their attending physician, and each test must be conducted by the healthcare provider providing prenatal care according to nationally recognized clinical practice guidelines. The division of TennCare is authorized to create rules and take administrative actions to implement this requirement, including potentially submitting new waiver applications to the federal Centers for Medicare and Medicaid Services (CMS) to ensure federal financial participation. The bill will take effect immediately for administrative purposes but will be fully implemented on July 1, 2025, to give health insurance carriers time to adjust their coverage plans.

Business and Industry, Health and Social Services

https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=HB0070&ga=114